Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons

Journal of Neurochemistry

Volumn 87, Issue 4, 2003, Pages 861-867

  Montañez, Sylvia ^a,b   Daws, Lynette C ^a   Gould, Georgianna G ^b   Frazer, Alan ^b,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

5; 7 DHT; CA3 region of hippocampus; Chronoamperometry; Degeneration; Rat; Serotonin transporter

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; FLUVOXAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

AMPEROMETRY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR FLUID; HIPPOCAMPUS; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCHEMISTRY; ELECTRODES, IMPLANTED; EXTRACELLULAR FLUID; FLUVOXAMINE; HIPPOCAMPUS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

ANIMALIA;

EID: 0345687499     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02032.x     Document Type: Article

References (35)

1. Abercrombie E. D., Bonatz A. E. and Zigmond M. J. (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525, 36-44.
2. Altar C. A. and Marien M. R. (1989) Preservation of dopamine release in the denervated striatum. Neurosci. Lett. 96, 329-334.
3. Bengel D., Murphy D. L., Andrews A. M., Wichems C. H., Feltner D., Heils A., Mössner R., Westphal H. and Lesch K.-P. (1998) Altered brain serotonin homestatis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ('ecstasy') in serotonin transporter-deficient mice. Mol. Pharmacol. 53, 649-655.
4. Benmansour S., Cecchi M., Morilak D. A., Gerhardt G. A., Javors M. A., Gould G. G. and Frazer A. (1999) Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J. Neurosci. 19, 10494-10501.
5. Benmansour S., Owens W. A., Cecchi M., Morilak D. A. and Frazer A. (2002) Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J. Neurosci. 22, 6766-6772.
6. Blakely R. D., Berson H. E., Fremeau R. T. Jr, Caron M. G., Peek M. M., Prince H. K. and Bradley C. C. (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66-70.
7. Cass W. A., Gerhardt G. A., Zhang Z., Ovadia A. and Gash D. M. (1995) Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions. Neurosci. Lett. 185, 52-55.
8. Daws L. C., Toney G. M., Davis D. J., Gerhardt G. A. and Frazer A. (1997) In vivo chronoamperometric measurements of the clearance of exogenously applied serotonin in the rat dentate gyrus. J. Neurosci. Methods 78, 139-150.
9. Daws L. C., Toney G. M., Gerhardt G. A. and Frazer A. (1998) In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J. Pharmacol. Exp. Ther 286, 967-976.
10. 1B receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J. Neurosci. 75, 2113-2122.
11. Daws L. C., Montañez S., Gould G. G., Gerhardt G. A. and Frazer A. (2000b) In vivo kinetics of serotonin clearance is dependent on brain region and density of serotonin and norepinephrine transporters. Soc. Neurosci. Abstr 26, 1668.
12. Duman R. S. (1998) Novel therapeutic approaches beyond the serotonin receptor. Biol. Psychiatry 44, 324-335.
13. Frazer A. (1997) Antidepressants. J. Clin. Psychiatry 58, 9-25.
14. Garris P. A., Walker Q. D. and Wightman R. M. (1997) Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals. Brain Res. 75, 3225-3234.
15. Geary I. I. W. A., Tioga A. W. and Wooten G. F. (1985) Quantitative film autoradiography for tritium: methodological considerations. Brain Res. 337, 99-108.
16. Gerhardt G. A. and Hoffman A. F. (2001) Effects of recording media composition on the responses of Nafion-coated fiber microelectrodes measured using high-speed chronoamperometry. J. Neurosci. Methods 109, 13-21.
17. Gershanik O. S., Heikkila R. E. and Duvoisin R. C. (1979) Asymmetric action of intracerebroventricular monoamine neurotoxins. Brain Res. 174, 345-350.
18. Gilmor M. L., Owens M. J. and Nemeroff C. B. (2002) Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. Am. J. Psychiatry 159, 1702-1710.
19. Hefti F., Melamed E. and Wurtman R. J. (1980) Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195, 123-137.
20. Hoffman B. J., Mezey E. and Brownstein M. J. (1991) Cloning of a serotonin transporter affected by antidepressants. Science 254, 579-580.
21. 3H]cyanoimipramine. Brain Res. 454, 78-88.
22. IIC]DASB PET imaging study. Am. J. Psychiatry 158, 1843-1849.
23. Montañez S., Daws L. C., Gould G. G., Gerhardt G. A. and Frazer A. (2002) Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Res. 955, 236-244.
24. Montañez S., Owens W. A., Gould G. G., Murphy D. L. and Daws L. C. (2003) Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J. Neurochem. 86, 210-219.
25. Nicholson C. (1995) Interaction between diffusion and Michaelis-Menten uptake of dopamine following iontophoresis in striatum. Biophys. J. 68, 1699-1715.
26. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
27. Pirker W., Asenbaum S., Kasper S., Walter H., Angelberger P., Koch G., Pozzera A., Deecke L., Podreka I. and Brücke T (1995) β-CIT SPECT demonstrates blockade of 5-HT-uptake sites by citalopram in the human brain in vivo. J. Neural Transm. 100, 247-256.
28. Robinson T. E. and Whishaw I. Q. (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450, 209-224.
29. Romero L., Bel N., Casanovas J. M. and Artigas F. (1996) Two actions are better than one: avoiding self-inhibition of serotonergic neurons enhances the effects of serotonin uptake inhibitors. Int. Clin. Psychopharmacol. 11, 1-8.
30. Shaskan E. G. and Snyder S. H. (1970) Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J. Pharmacol. Exp. Ther. 175, 404-418.
31. Stachowiak M. K., Stricker E. M., Jacoby J. H. and Zigmond M. J. (1986) Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem. Pharmacol. 35, 1241-1248.
32. Van Home C., Hoffer B. J., Strömberg I. and Gerhardt G. A. (1992) Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J. Pharmacol. Exp. Ther. 263, 1285-1292.
33. Zhang W. Q., Tilson H. A., Nanry K. P., Hudson P. M., Hong J. S. and Stachowiak M. K. (1988) Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res. 461, 335-342.
34. Zigmond M. J., Acheson A. L., Stachowiak M. K. and Strickerm E. M. (1984) Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol. 41, 856-861.
35. Zigmond M. J. and Stricker E. M. (1984) Parkinson's disease: studies with an animal model. Life Sci. 35, 5-18.